Year: 2025
Type: article
Source: Blood Advances
Authors: Melinda S. Y. Tan, Rahma Warsame, Ricardo Parrondo, Eli Muchtar, Taxiarchis Kourelis, Francis Buadi, Wilson Gonsalves, Joselle Cook, Prashant Kapoor, Suzanne Hayman, David Dingli, Moritz Binder, Nelson Leung, Vivek Roy, Taimur Sher, J. Erin Wiedmeier-Nutor, Saurabh Chhabra, Rafael Fonseca, Nadine Abdallah, S. Vincent Rajkumar, Shaji K. Kumar, Morie Gertz, Yi Lin, Angela Dispenzieri
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,800
Funders: Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Celgene, Karyopharm Therapeutics, Regeneron Pharmaceuticals, Prothena, bluebird bio, BeiGene, Apellis Pharmaceuticals, Ascentage Pharma, Swedish Orphan Biovitrum, Genentech, Pharmacyclics, Legend Biotech
OpenAlex ID: W4415237828
